Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

0.7826
Delayed Data
As of Sep 22
 +0.0147 / +1.91%
Today’s Change
0.68
Today|||52-Week Range
2.65
-46.40%
Year-to-Date
No recent news for Adaptimmune Therapeutics PLC.

Today’s Trading

Previous close0.77
Today’s open0.76
Day’s range0.76 - 0.78
Volume31,367
Average volume (3 months)758,061
Market cap$174.4M
Data as of 3:59pm ET, 09/22/2023

Growth & Valuation

Earnings growth (last year)-1.10%
Earnings growth (this year)-185.88%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+341.28%
P/E ratioNM
Price/Sales8.67
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
LRMRLarimar Therapeutics...+0.12+2.93%
ATRAAtara Biotherapeutic...0.000.00%
XOMAXOMA Corp-0.34-2.16%
MREOMereo Biopharma Grou...+0.04+3.01%
Data as of 3:59pm ET, 09/22/2023

Financials

Next reporting dateNovember 2, 2023
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$27.1M
Annual profit (last year)-$165.4M
Net profit margin-609.46%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts